Trial · NCT07116577
Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC
NCT07116577, Phase 2, Not yet recruiting, Jinan Central Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC. Trials, record NCT07116577. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07116577
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC
- NCT number
- NCT07116577
- Status
- Not yet recruiting
- Phases
- Phase 2
- Enrollment
- 37 participants, estimated
- Lead sponsor
- Jinan Central Hospital
- Conditions
- mCRC
- Interventions
- Palliative radiotherapy, Iparomlimab and tuvonralimab, TAS-102, Bevacizumab
- First posted
- 2025-08-11
- Last updated
- 2025-08-11
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | ORR | approximately 4 months after the last subject participating in | The time from the date for first documented response of complete response (CR) or partial response (PR) to the date of first documented of disease progression or death, whichever occurs first. |
| Secondary | PFS | approximately 12 months after the last subject participating in | the proportion of subjects with complete response (CR) and partial response (PR) according RESIST1.1 in total subjects. |
| Secondary | OS | approximately 12 months after the last subject participating in | The time from the starting date of study drug to the date of death due to any cause. |
| Secondary | DCR | approximately 4 months after the last subject participating in | The proportion of subjects with complete response (CR) and partial response (PR) and stable disease(SD) in total subjects |
| Secondary | Safety (adverse event) | Up to approximately 2 years. | The rates of adverse events. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07116577
GET https://conductscience.org/api/trials/v1/NCT07116577/registered